Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

NCT06511050 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Long Covid
Post-treatment Lyme Disease Syndrome
Chronic Fatigue Syndrome
Myalgic Encephalomyelitis

Interventions

DIETARY_SUPPLEMENT: Lumbrokinase

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]